Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Reconsidering India as a Clinical Trial Location Infographic

Revised regulations in India warrant a fresh look as a viable country to run clinical trials. See why in our whitepaper.